Methocarbamol (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Methocarbamol" in English language version.

refsWebsite

Global rank English rank

20nih.gov

4^th place

14doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

4web.archive.org

1^st place

3drugs.com

399^th place

333^rd place

2clincalc.com

3,912^th place

2,496^th place

2books.google.com

3^rd place

2worldcat.org

5^th place

1medicines.org.uk

3,823^rd place

2,387^th place

1canada.ca

1,712^th place

1,063^rd place

1medlineplus.gov

1,581^st place

1,299^th place

1dcri.org

low place

1ctchealth.ca

low place

1esi-canada.com

low place

1tylenol.ca

low place

books.google.com

Fine PG (2016). The Hospice Companion: Best Practices for Interdisciplinary Care of Advanced Illness. Oxford University Press. p. PT146. ISBN 978-0-19-045692-4.
Robbins LD (2013). Management of Headache and Headache Medications. Springer Science & Business Media. p. PT147. ISBN 978-1-4612-2124-1.

canada.ca

health-products.canada.ca

"Summit Ultra Product information". Health Canada. 2 August 2018. Retrieved 17 February 2025.

clincalc.com

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Methocarbamol Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.

ctchealth.ca

"ROBAXIN product appearance in Canada". ctchealth.ca. 13 July 2021. Retrieved 13 December 2021.

dcri.org

"Beers Criteria Medication List". DCRI. Archived from the original on 7 November 2020. Retrieved 18 October 2020.

doi.org

Sica DA, Comstock TJ, Davis J, Manning L, Powell R, Melikian A, et al. (1990). "Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals". European Journal of Clinical Pharmacology. 39 (2): 193–194. doi:10.1007/BF00280060. PMID 2253675. S2CID 626920.
Richards BL, Whittle SL, Buchbinder R (January 2012). "Muscle relaxants for pain management in rheumatoid arthritis". The Cochrane Database of Systematic Reviews. 1 (1): CD008922. doi:10.1002/14651858.CD008922.pub2. PMC 11702505. PMID 22258993. S2CID 73769165.
Chou R, Peterson K, Helfand M (August 2004). "Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review". Journal of Pain and Symptom Management. 28 (2): 140–175. doi:10.1016/j.jpainsymman.2004.05.002. PMID 15276195.
Spence MM, Shin PJ, Lee EA, Gibbs NE (July 2013). "Risk of injury associated with skeletal muscle relaxant use in older adults". The Annals of Pharmacotherapy. 47 (7–8): 993–998. doi:10.1345/aph.1R735. PMID 23821610. S2CID 9037478.
Preston KL, Wolf B, Guarino JJ, Griffiths RR (August 1992). "Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability". The Journal of Pharmacology and Experimental Therapeutics. 262 (2): 707–720. doi:10.1016/S0022-3565(25)10815-X. PMID 1501118.
Bruce RB, Turnbull LB, Newman JH (January 1971). "Metabolism of methocarbamol in the rat, dog, and human". Journal of Pharmaceutical Sciences. 60 (1): 104–106. doi:10.1002/jps.2600600120. PMID 5548215.
Friedman BW, Cisewski D, Irizarry E, Davitt M, Solorzano C, Nassery A, et al. (March 2018). "A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain". Annals of Emergency Medicine. 71 (3): 348–356.e5. doi:10.1016/j.annemergmed.2017.09.031. PMC 5820149. PMID 29089169.
Chou R, Huffman LH (October 2007). "Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline". Annals of Internal Medicine. 147 (7): 505–514. doi:10.7326/0003-4819-147-7-200710020-00008. PMID 17909211. S2CID 32719708.
Cherkin DC, Wheeler KJ, Barlow W, Deyo RA (March 1998). "Medication use for low back pain in primary care". Spine. 23 (5): 607–614. doi:10.1097/00007632-199803010-00015. PMID 9530793. S2CID 23664539.
Luo X, Pietrobon R, Curtis LH, Hey LA (December 2004). "Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States". Spine. 29 (23): E531 – E537. doi:10.1097/01.brs.0000146453.76528.7c. PMID 15564901. S2CID 72742439.
Patanwala AE, Aljuhani O, Kopp BJ, Erstad BL (October 2017). "Methocarbamol use is associated with decreased hospital length of stay in trauma patients with closed rib fractures". American Journal of Surgery. 214 (4): 738–742. doi:10.1016/j.amjsurg.2017.01.003. PMID 28088301.
Deloney L, Smith M, Carter C, Privette A, Leon S, Eriksson E (January 2020). "946: Methocarbamol reduces opioid use and length of stay in young adults with traumatic rib fractures". Critical Care Medicine. 48 (1): 452. doi:10.1097/01.ccm.0000633320.62811.06. ISSN 0090-3493.
Smith M, Deloney L, Carter C, Leon S, Privette A, Eriksson E (January 2020). "1759: Use of methocarbamol in geriatric patients with rib fractures is associated with improved outcomes". Critical Care Medicine. 48 (1): 854. doi:10.1097/01.ccm.0000649332.10326.98. ISSN 0090-3493.
Aljuhani O, Kopp BJ, Patanwala AE (2017). "Effect of Methocarbamol on Acute Pain After Traumatic Injury". American Journal of Therapeutics. 24 (2): e202 – e206. doi:10.1097/mjt.0000000000000364. PMID 26469684. S2CID 24284482.

drugs.com

"Methocarbamol Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists.
"Methocarbamol Side Effects: Common, Severe, Long Term". Drugs.com. Retrieved 18 April 2020.
"Methocarbamol". Drugs.com. Retrieved 12 May 2018.

esi-canada.com

"New Drugs and Indications Reviewed at the May 2003 DEC Meeting" (PDF). ESI Canada. Archived from the original (PDF) on 10 July 2011. Retrieved 14 November 2008.

medicines.org.uk

"Robaxin-750 - Summary of Product Characteristics (SmPC)". (emc). 8 August 2017. Retrieved 19 April 2020.

medlineplus.gov

"Methocarbamol". MedlinePlus. Retrieved 18 April 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sica DA, Comstock TJ, Davis J, Manning L, Powell R, Melikian A, et al. (1990). "Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals". European Journal of Clinical Pharmacology. 39 (2): 193–194. doi:10.1007/BF00280060. PMID 2253675. S2CID 626920.
Richards BL, Whittle SL, Buchbinder R (January 2012). "Muscle relaxants for pain management in rheumatoid arthritis". The Cochrane Database of Systematic Reviews. 1 (1): CD008922. doi:10.1002/14651858.CD008922.pub2. PMC 11702505. PMID 22258993. S2CID 73769165.
"Methocarbamol". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. 30 January 2017. PMID 31643609.
Chou R, Peterson K, Helfand M (August 2004). "Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review". Journal of Pain and Symptom Management. 28 (2): 140–175. doi:10.1016/j.jpainsymman.2004.05.002. PMID 15276195.
See S, Ginzburg R (August 2008). "Choosing a skeletal muscle relaxant". American Family Physician. 78 (3): 365–370. PMID 18711953.
Spence MM, Shin PJ, Lee EA, Gibbs NE (July 2013). "Risk of injury associated with skeletal muscle relaxant use in older adults". The Annals of Pharmacotherapy. 47 (7–8): 993–998. doi:10.1345/aph.1R735. PMID 23821610. S2CID 9037478.
Preston KL, Wolf B, Guarino JJ, Griffiths RR (August 1992). "Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability". The Journal of Pharmacology and Experimental Therapeutics. 262 (2): 707–720. doi:10.1016/S0022-3565(25)10815-X. PMID 1501118.
Bruce RB, Turnbull LB, Newman JH (January 1971). "Metabolism of methocarbamol in the rat, dog, and human". Journal of Pharmaceutical Sciences. 60 (1): 104–106. doi:10.1002/jps.2600600120. PMID 5548215.
Friedman BW, Cisewski D, Irizarry E, Davitt M, Solorzano C, Nassery A, et al. (March 2018). "A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain". Annals of Emergency Medicine. 71 (3): 348–356.e5. doi:10.1016/j.annemergmed.2017.09.031. PMC 5820149. PMID 29089169.
Chou R, Huffman LH (October 2007). "Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline". Annals of Internal Medicine. 147 (7): 505–514. doi:10.7326/0003-4819-147-7-200710020-00008. PMID 17909211. S2CID 32719708.
Cherkin DC, Wheeler KJ, Barlow W, Deyo RA (March 1998). "Medication use for low back pain in primary care". Spine. 23 (5): 607–614. doi:10.1097/00007632-199803010-00015. PMID 9530793. S2CID 23664539.
Luo X, Pietrobon R, Curtis LH, Hey LA (December 2004). "Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States". Spine. 29 (23): E531 – E537. doi:10.1097/01.brs.0000146453.76528.7c. PMID 15564901. S2CID 72742439.
Patanwala AE, Aljuhani O, Kopp BJ, Erstad BL (October 2017). "Methocarbamol use is associated with decreased hospital length of stay in trauma patients with closed rib fractures". American Journal of Surgery. 214 (4): 738–742. doi:10.1016/j.amjsurg.2017.01.003. PMID 28088301.
Aljuhani O, Kopp BJ, Patanwala AE (2017). "Effect of Methocarbamol on Acute Pain After Traumatic Injury". American Journal of Therapeutics. 24 (2): e202 – e206. doi:10.1097/mjt.0000000000000364. PMID 26469684. S2CID 24284482.

ncbi.nlm.nih.gov

Richards BL, Whittle SL, Buchbinder R (January 2012). "Muscle relaxants for pain management in rheumatoid arthritis". The Cochrane Database of Systematic Reviews. 1 (1): CD008922. doi:10.1002/14651858.CD008922.pub2. PMC 11702505. PMID 22258993. S2CID 73769165.
"Methocarbamol". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. 30 January 2017. PMID 31643609.
Friedman BW, Cisewski D, Irizarry E, Davitt M, Solorzano C, Nassery A, et al. (March 2018). "A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain". Annals of Emergency Medicine. 71 (3): 348–356.e5. doi:10.1016/j.annemergmed.2017.09.031. PMC 5820149. PMID 29089169.

dailymed.nlm.nih.gov

"Robaxin- methocarbamol tablet, film coated". DailyMed. 18 July 2019. Retrieved 19 April 2020.
"Robaxin- methocarbamol injection". DailyMed. 10 December 2018. Retrieved 19 April 2020.

pubchem.ncbi.nlm.nih.gov

"Methocarbamol". PubChem. U.S. National Library of Medicine. Retrieved 6 July 2020.

semanticscholar.org

api.semanticscholar.org

Sica DA, Comstock TJ, Davis J, Manning L, Powell R, Melikian A, et al. (1990). "Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals". European Journal of Clinical Pharmacology. 39 (2): 193–194. doi:10.1007/BF00280060. PMID 2253675. S2CID 626920.
Richards BL, Whittle SL, Buchbinder R (January 2012). "Muscle relaxants for pain management in rheumatoid arthritis". The Cochrane Database of Systematic Reviews. 1 (1): CD008922. doi:10.1002/14651858.CD008922.pub2. PMC 11702505. PMID 22258993. S2CID 73769165.
Spence MM, Shin PJ, Lee EA, Gibbs NE (July 2013). "Risk of injury associated with skeletal muscle relaxant use in older adults". The Annals of Pharmacotherapy. 47 (7–8): 993–998. doi:10.1345/aph.1R735. PMID 23821610. S2CID 9037478.
Chou R, Huffman LH (October 2007). "Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline". Annals of Internal Medicine. 147 (7): 505–514. doi:10.7326/0003-4819-147-7-200710020-00008. PMID 17909211. S2CID 32719708.
Cherkin DC, Wheeler KJ, Barlow W, Deyo RA (March 1998). "Medication use for low back pain in primary care". Spine. 23 (5): 607–614. doi:10.1097/00007632-199803010-00015. PMID 9530793. S2CID 23664539.
Luo X, Pietrobon R, Curtis LH, Hey LA (December 2004). "Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States". Spine. 29 (23): E531 – E537. doi:10.1097/01.brs.0000146453.76528.7c. PMID 15564901. S2CID 72742439.
Aljuhani O, Kopp BJ, Patanwala AE (2017). "Effect of Methocarbamol on Acute Pain After Traumatic Injury". American Journal of Therapeutics. 24 (2): e202 – e206. doi:10.1097/mjt.0000000000000364. PMID 26469684. S2CID 24284482.

tylenol.ca

"Tylenol Body Pain Night Overview and Dosage". Tylenol Canada. Archived from the original (website) on 31 March 2012. Retrieved 23 April 2012.

web.archive.org

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Beers Criteria Medication List". DCRI. Archived from the original on 7 November 2020. Retrieved 18 October 2020.
"New Drugs and Indications Reviewed at the May 2003 DEC Meeting" (PDF). ESI Canada. Archived from the original (PDF) on 10 July 2011. Retrieved 14 November 2008.
"Tylenol Body Pain Night Overview and Dosage". Tylenol Canada. Archived from the original (website) on 31 March 2012. Retrieved 23 April 2012.

worldcat.org

search.worldcat.org

Deloney L, Smith M, Carter C, Privette A, Leon S, Eriksson E (January 2020). "946: Methocarbamol reduces opioid use and length of stay in young adults with traumatic rib fractures". Critical Care Medicine. 48 (1): 452. doi:10.1097/01.ccm.0000633320.62811.06. ISSN 0090-3493.
Smith M, Deloney L, Carter C, Leon S, Privette A, Eriksson E (January 2020). "1759: Use of methocarbamol in geriatric patients with rib fractures is associated with improved outcomes". Critical Care Medicine. 48 (1): 854. doi:10.1097/01.ccm.0000649332.10326.98. ISSN 0090-3493.